BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Takahashi M, Mutoh M, Ishigamori R, Fujii G, Imai T. Involvement of inflammatory factors in pancreatic carcinogenesis and preventive effects of anti-inflammatory agents. Semin Immunopathol. 2013;35:203-227. [PMID: 22955327 DOI: 10.1007/s00281-012-0340-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Sbeit W, Mari A, Pellicano R, Khoury T. Fatty pancreas and pancreatic cancer: a new player on the field? Minerva Gastroenterol (Torino) 2021;67:65-6. [PMID: 32883052 DOI: 10.23736/S2724-5985.20.02758-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Cheng RY, Basudhar D, Ridnour LA, Heinecke JL, Kesarwala AH, Glynn S, Switzer CH, Ambs S, Miranda KM, Wink DA. Gene expression profiles of NO- and HNO-donor treated breast cancer cells: insights into tumor response and resistance pathways. Nitric Oxide 2014;43:17-28. [PMID: 25153034 DOI: 10.1016/j.niox.2014.08.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
3 Pinho AV, Chantrill L, Rooman I. Chronic pancreatitis: a path to pancreatic cancer. Cancer Lett. 2014;345:203-209. [PMID: 23981573 DOI: 10.1016/j.canlet.2013.08.015] [Cited by in Crossref: 85] [Cited by in F6Publishing: 76] [Article Influence: 9.4] [Reference Citation Analysis]
4 Guzmán EA, Maers K, Roberts J, Kemami-Wangun HV, Harmody D, Wright AE. The marine natural product microsclerodermin A is a novel inhibitor of the nuclear factor kappa B and induces apoptosis in pancreatic cancer cells. Invest New Drugs 2015;33:86-94. [PMID: 25416019 DOI: 10.1007/s10637-014-0185-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
5 Mohammed A, Janakiram NB, Madka V, Brewer M, Ritchie RL, Lightfoot S, Kumar G, Sadeghi M, Patlolla JM, Yamada HY. Targeting pancreatitis blocks tumor-initiating stem cells and pancreatic cancer progression. Oncotarget. 2015;6:15524-15539. [PMID: 25906749 DOI: 10.18632/oncotarget.3499] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
6 Duan X, Wang W, Pan Q, Guo L. Type 2 Diabetes Mellitus Intersects With Pancreatic Cancer Diagnosis and Development. Front Oncol 2021;11:730038. [PMID: 34485159 DOI: 10.3389/fonc.2021.730038] [Reference Citation Analysis]
7 Li J, Liu ZM. Selective COX-2 inhibitors for treatment of pancreatic cancer: Research progress. Shijie Huaren Xiaohua Zazhi 2013; 21(15): 1394-1399 [DOI: 10.11569/wcjd.v21.i15.1394] [Reference Citation Analysis]
8 Lee SH, Park SW. [Inflammation and Cancer Development in Pancreatic and Biliary Tract Cancer]. Korean J Gastroenterol 2015;66:325-39. [PMID: 26691190 DOI: 10.4166/kjg.2015.66.6.325] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
9 Moriya C, Imai K, Taniguchi H. PRDM14 is overexpressed in chronic pancreatitis prior to pancreatic cancer. FEBS Open Bio 2018;8:1733-41. [PMID: 30338223 DOI: 10.1002/2211-5463.12519] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]